ASPARAGINASE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where ASPARAGINASE was used for Neoplasm malignant.
Most Reported Side Effects for ASPARAGINASE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 557 | 11.2% | 96 | 270 |
| Neutropenia | 322 | 6.5% | 50 | 130 |
| Bacterial infection | 295 | 5.9% | 255 | 10 |
| Off label use | 267 | 5.4% | 118 | 88 |
| Secondary immunodeficiency | 233 | 4.7% | 212 | 3 |
| Viral infection | 228 | 4.6% | 228 | 3 |
| Clostridium difficile colitis | 213 | 4.3% | 201 | 16 |
| Pyrexia | 204 | 4.1% | 39 | 123 |
| Sepsis | 200 | 4.0% | 95 | 70 |
| Pneumonia | 196 | 3.9% | 143 | 41 |
| Posterior reversible encephalopathy syndrome | 195 | 3.9% | 4 | 63 |
| Bronchopulmonary aspergillosis | 194 | 3.9% | 163 | 11 |
| Drug ineffective | 192 | 3.9% | 72 | 59 |
| Mycobacterium chelonae infection | 170 | 3.4% | 170 | 1 |
| Death | 169 | 3.4% | 169 | 10 |
Other Indications for ASPARAGINASE
Acute lymphocytic leukaemia (2,690)
T-cell type acute leukaemia (282)
Product used for unknown indication (278)
B precursor type acute leukaemia (214)
B-cell type acute leukaemia (207)
Angiocentric lymphoma (148)
Non-hodgkin's lymphoma (135)
Precursor t-lymphoblastic lymphoma/leukaemia (118)
Chemotherapy (98)
Acute myeloid leukaemia (68)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)